Figure 2
Concentration–time pharmacokinetic profiles (mean±standard deviation) for all the evaluated dose levels of seliciclib (100, 200, 800 mg) on both days 1 (A) and 7 (B).
Figure 2 | British Journal of Cancer
Concentration–time pharmacokinetic profiles (mean±standard deviation) for all the evaluated dose levels of seliciclib (100, 200, 800 mg) on both days 1 (A) and 7 (B).
